Abbott is done investigating a former employee’s allegations about quality-control problems at its Michigan infant formula plant but impacts on revenues from temporarily shutting down the facility aren’t done with the firm.
Another impact from the shutdown and Abbott’s related recall of three of its major formula brands the firm announced with its lasts results on 19 October is a plan to invest
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?